Brickell Biotech Performance
| BBIDelisted Stock | USD 1.79 0.34 23.45% |
The firm shows a Beta (market volatility) of 0.85, which signifies possible diversification benefits within a given portfolio. Brickell Biotech returns are very sensitive to returns on the market. As the market goes up or down, Brickell Biotech is expected to follow. Brickell Biotech right now shows a risk of 0.0%. Please confirm Brickell Biotech total risk alpha, kurtosis, market facilitation index, as well as the relationship between the value at risk and rate of daily change , to decide if Brickell Biotech will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Brickell Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Brickell Biotech is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 30.1 M | |
| Total Cashflows From Investing Activities | -36 K |
Brickell |
Brickell Biotech Relative Risk vs. Return Landscape
If you would invest 179.00 in Brickell Biotech on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Brickell Biotech or generate 0.0% return on investment over 90 days. Brickell Biotech is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Brickell, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Brickell Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brickell Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Brickell Biotech, and traders can use it to determine the average amount a Brickell Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BBI |
Based on monthly moving average Brickell Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brickell Biotech by adding Brickell Biotech to a well-diversified portfolio.
Brickell Biotech Fundamentals Growth
Brickell Stock prices reflect investors' perceptions of the future prospects and financial health of Brickell Biotech, and Brickell Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brickell Stock performance.
| Return On Equity | -1.57 | |||
| Return On Asset | -0.8 | |||
| Operating Margin | (6.58) % | |||
| Current Valuation | (8.35 M) | |||
| Shares Outstanding | 2.87 M | |||
| Price To Earning | (35.16) X | |||
| Price To Book | 0.41 X | |||
| Price To Sales | 1.45 X | |||
| Revenue | 404 K | |||
| EBITDA | (39.38 M) | |||
| Cash And Equivalents | 17.29 M | |||
| Cash Per Share | 6.52 X | |||
| Total Debt | 69 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 5.81 X | |||
| Cash Flow From Operations | (36.15 M) | |||
| Earnings Per Share | (0.42) X | |||
| Total Asset | 29.72 M | |||
| Retained Earnings | (145.37 M) | |||
| Current Asset | 52.66 M | |||
| Current Liabilities | 5.61 M | |||
About Brickell Biotech Performance
By evaluating Brickell Biotech's fundamental ratios, stakeholders can gain valuable insights into Brickell Biotech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Brickell Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Brickell Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company was founded in 2009 and is headquartered in Boulder, Colorado. Brickell Biotech operates under Biotechnology classification in the United States and is traded on NCM Exchange. It employs 16 people.Things to note about Brickell Biotech performance evaluation
Checking the ongoing alerts about Brickell Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Brickell Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brickell Biotech is not yet fully synchronised with the market data | |
| Brickell Biotech may become a speculative penny stock | |
| Brickell Biotech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 404 K. Reported Net Loss for the year was (39.47 M) with loss before taxes, overhead, and interest of (27.83 M). | |
| Brickell Biotech has about 17.29 M in cash with (36.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Brickell Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brickell Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Brickell Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brickell Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brickell Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brickell Biotech's stock. These opinions can provide insight into Brickell Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Brickell Stock
If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |